The ever-present specter of neonatal sepsis is an escalating existential threat in nations such as Nigeria and Ethiopia, posing a significant risk to newborn survival. The scenarios are made more grave as antibiotic-resistant bacteria proliferate massively, amplifying the crisis.
Consider Yusra, a newborn with delicate health, her undersized frame concealed by the machinery dedicated to her survival. Born prematurely in tumultuous Ethiopia via C-section, Yusra developed a severe case of neonatal sepsis, a medical condition in which the body’s immune system implodes, attacking the very organs it’s meant to safeguard. Despite continuous attempts to combat her condition using a spectrum of antibiotics, the drugs had no effect. Yusra’s tragic tale, unfortunately, encapsulates the burgeoning global crisis surrounding deadly, drug-resistant infections.
According to data from 2019, drug-resistant infections were correlated with nearly 5 million deaths globally, surpassing fatalities caused by HIV and malaria combined. Over 20% of these cases emerged from sub-Saharan Africa, where access to life-saving medications can be challenging due to shortages, erroneous prescriptions, and prohibitive costs.
Antibiotics have long formed the foundation of modern medicine, mitigating the risk of fatal infections resulting from routine surgery, child delivery, and even minor wounds. However, the frequent overuse of these drugs, coupled with clean water, sanitation, and hygiene deficiencies, has promoted a distressing increase in antibiotic resistance, resulting in once easily treated infections turning fatal.
Crumbling facilities, insufficient testing equipment, and inadequate resources deprive medical practitioners of vital diagnostic capabilities. Consequently, medical treatment often involves empirical decisions based on clinical judgement, leading to the prescription of antibiotics on an educated guess, further exacerbating the problem.
In Nigeria, where one in 29 infants fails to survive the first four weeks due to sepsis, the fight against drug-resistant infections is particularly brutal for premature babies like Yusra. The cost of antibiotics often falls on parents or relies on hospital donors, financially burdening families and exhausting resources. This problem extends to Ethiopia, where the cost of last-resort antibiotics can exceed average monthly wages by five times.
Analogous circumstances persist across African hospitals in hospitals where the scarcity of resources and clean water compel medical staff to share equipment and medication among patients, further perpetuating the spread of infections. If inadequately sterilized, equipment becomes vulnerable to bacterial contamination.
Incidences such as Yusra’s tale amplify the need for a transformative approach towards infection prevention and control. Only through a combative addressal of these issues in hospital settings can we hope to subdue the alarming rise of drug-resistant infections. While some measures have yielded successes, as evidenced by the decline in infections in a Lagos neonatal ward through cheat sheets for antibiotics, they remain far from sufficient.